SynthesisThoracic cancer2023

Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.

Tzu-Rong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.